Back to Search Start Over

The role of RNA binding proteins in hepatocellular carcinoma.

Authors :
Zhang K
Barry AE
Lamm R
Patel K
Schafer M
Dang H
Source :
Advanced drug delivery reviews [Adv Drug Deliv Rev] 2022 Mar; Vol. 182, pp. 114114. Date of Electronic Publication: 2022 Jan 19.
Publication Year :
2022

Abstract

Hepatocellular carcinoma (HCC) is one of the leading causes of overall cancer deaths worldwide with limited therapeutic options. Due to the heterogeneity of HCC pathogenesis, the molecular mechanisms underlying HCC development are not fully understood. Emerging evidence indicates that RNA-binding proteins (RBPs) play a vital role throughout hepatocarcinogenesis. Thus, a deeper understanding of how RBPs contribute to HCC progression will provide new tools for early diagnosis and prognosis of this devastating disease. In this review, we summarize the tumor suppressive and oncogenic roles of RBPs and their roles in hepatocarcinogenesis. The diagnostic and therapeutic potential of RBPs in HCC, including their limitations, are also discussed.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2022 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-8294
Volume :
182
Database :
MEDLINE
Journal :
Advanced drug delivery reviews
Publication Type :
Academic Journal
Accession number :
35063534
Full Text :
https://doi.org/10.1016/j.addr.2022.114114